אולנזאפין דקסל 10 מ"ג

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

OLANZAPINE 10 MG

Mevcut itibaren:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC kodu:

N05AH03

Farmasötik formu:

TABLETS

Uygulama yolu:

PER OS

Tarafından üretildi:

DEXCEL LTD

Terapötik grubu:

OLANZAPINE

Terapötik endikasyonlar:

Acute and maintenance treatment of schizophrenia. Olanzapine is indicated for the management of the manifestations of psychotic disorders. Olanzapine is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder : the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Yetkilendirme tarihi:

2012-05-01